Susceptibility markers in normal subjects: A pilot study for the investigation of 2,3,7,8-tetrachlorodibenzo-p-dioxin related diseases

[1]  D. Consonni,et al.  Cancer morbidity in the Seveso area, 1976–1986 , 1992 .

[2]  B. Pasternack,et al.  Expression of the CYP1A1 gene in peripheral lymphocytes as a marker of exposure to creosote in railroad workers. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[3]  A. Brøgger,et al.  Human CYP1A1 (cytochrome P(1)450) gene: lack of association between the Msp I restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. , 1991, Pharmacogenetics.

[4]  K. Nakachi,et al.  Genetic linkage of lung cancer-associated MspI polymorphisms with amino acid replacement in the heme binding region of the human cytochrome P450IA1 gene. , 1991, Journal of biochemistry.

[5]  K. Nakachi,et al.  Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P45 0IA1 gene , 1990, FEBS letters.

[6]  J. Whitlock,et al.  Genetic and molecular aspects of 2,3,7,8-tetrachlorodibenzo-p-dioxin action. , 1990, Annual review of pharmacology and toxicology.

[7]  G. Lucier,et al.  Relationships among benzo(a)pyrene metabolism, benzo(a)pyrene-diol-epoxide:DNA adduct formation, and sister chromatid exchanges in human lymphocytes from smokers and nonsmokers. , 1989, Cancer research.

[8]  S Guercilena,et al.  Ten-year mortality study of the population involved in the Seveso incident in 1976. , 1989, American journal of epidemiology.

[9]  H. Beck,et al.  PCDD and PCDF body burden from food intake in the Federal Republic of Germany , 1989 .

[10]  F. H. Ebetino,et al.  Photoaffinity labeling of the Ah receptor. , 1986, The Journal of biological chemistry.

[11]  A. N. Tucker,et al.  Suppression of B cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. , 1986, Molecular pharmacology.

[12]  J. V. Martin.  Lipid abnormalities in workers exposed to dioxin. , 1984, British journal of industrial medicine.

[13]  R. Sosnowski,et al.  Biological activity of tobacco smoke and tobacco smoke-related chemicals. , 1979, Environmental health perspectives.

[14]  V. Barnett,et al.  Applied Linear Statistical Models , 1975 .

[15]  C R Shaw,et al.  Aryl hydrocarbon hydroxylase inducibility and bronchogenic carcinoma. , 1973, The New England journal of medicine.